- Home
- ETN vs BMY Comparison
ETN vs BMY Comparison
Compare ETN & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETN
- BMY
- Stock Information
- Founded
- ETN 1916
- BMY 1887
- Country
- ETN Ireland
- BMY United States
- Employees
- ETN N/A
- BMY N/A
- Industry
- ETN Industrial Machinery/Components
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- ETN Technology
- BMY Health Care
- Exchange
- ETN Nasdaq
- BMY Nasdaq
- Market Cap
- ETN 133.6B
- BMY 115.3B
- IPO Year
- ETN N/A
- BMY N/A
- Fundamental
- Price
- ETN $297.34
- BMY $55.84
- Analyst Decision
- ETN Buy
- BMY Hold
- Analyst Count
- ETN 19
- BMY 14
- Target Price
- ETN $368.67
- BMY $58.00
- AVG Volume (30 Days)
- ETN 3.9M
- BMY 11.7M
- Earning Date
- ETN 01-31-2025
- BMY 02-06-2025
- Dividend Yield
- ETN 1.26%
- BMY 4.44%
- EPS Growth
- ETN 18.45
- BMY N/A
- EPS
- ETN 9.50
- BMY N/A
- Revenue
- ETN $24,878,000,000.00
- BMY $48,300,000,000.00
- Revenue This Year
- ETN $8.73
- BMY N/A
- Revenue Next Year
- ETN $7.44
- BMY N/A
- P/E Ratio
- ETN $31.30
- BMY N/A
- Revenue Growth
- ETN 7.25
- BMY 7.32
- 52 Week Low
- ETN $255.65
- BMY $39.35
- 52 Week High
- ETN $379.99
- BMY $61.10
- Technical
- Relative Strength Index (RSI)
- ETN 31.67
- BMY 45.21
- Support Level
- ETN $304.07
- BMY $53.54
- Resistance Level
- ETN $316.58
- BMY $56.54
- Average True Range (ATR)
- ETN 7.65
- BMY 1.41
- MACD
- ETN -0.71
- BMY -0.26
- Stochastic Oscillator
- ETN 8.09
- BMY 33.72
About ETN Eaton Corporation PLC
Founded in 1911 by Joseph Eaton, the eponymous company began by selling truck axles in New Jersey. Eaton has since become an industrial powerhouse largely through acquisitions in various end markets. Eaton's portfolio can broadly be divided into two parts: its electrical and industrial businesses. Its electrical portfolio (representing around 70% of company revenue) sells components within data centers, utilities, and commercial and residential buildings, while its industrial business (30% of revenue) sells components within commercial and passenger vehicles and aircraft. Eaton receives favorable tax treatment as a domiciliary of Ireland, but it generates over half of its revenue within the US.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.